Anxiety Flashcards
Anxiety disorders
Severe, excessive, persistent anxiety and irrational fears that impairs functioning
_____, a temporal lobe structure, plays a critical role in assessment of fear stimuli and learned response to fear.
Amygdala
“Fear circuit” and symptoms are regulated by the _____.
Amygdala
“Worry circuit” and symptoms are regulated by ________.
Cortico-striatal-thalanic-cortical (CSTC) loop
Defence System originates in _____, responsible for _____ responses, responds to both ____________ threats.
Amygdala
Fear, fight or flight
Learned & unlearned
Behavourial Inhibition System is based in ________, responsible for _________.
Hippocampus & septum of limbic system
Avoidance behaviour
In response to threat or fearful situations, the ____ serves as an alarm centre, activating ____ release and stimulating the sympathetic and parasympathetic nervous system.
Locus ceruleus (LC)
NE
Which neurotransmitters are dysregulated in anxiety?
NE
5HT
GABA
GABA is a major _____ neurotransmitter, with strong regulatory or inhibitory effect on __, __, __ systems.
Inhibitory
5-HT, DA, NE
Medications that reduce anxiety and produce sedation target the _____ receptor.
GABAA
When GABA binds to the GABAA receptor, neuronal excitability is _______.
Reduced
How is 5HT involved in Neurochemical dysregulation?
Pathological fear/anxiety is related to over-activation of the amygdala. However, the amygdala receives input from serotonergic neurons which can inhibit its outputs.
Generalised Anxiety Disorder (GAD)
Excessive anxiety and worries >6 months
Panic Disorder (PD)
Anticipatory anxiety of recurrent panic attacks
Social Anxiety Disorder (SAD)
Fear of being scrutinized or humiliated by others in public
Medical conditions associated with anxiety (1)
CVD - Angina, arrhythmias, CHF**, ischemic heart disease, myocardial infarction
Medical conditions associated with anxiety (2)
Metabolic - Cushing’s disease, hyperparathyroidism, hyperthyroidism**, hypoglyceamia, hyponatraemia, hyperkalaemia, pheochromocytoma, vitamin B12 or folic acid deficiencies
Medical conditions associated with anxiety (3)
Neurologic - Dementia, delirium, migraine, PD, seizures, stroke, neoplasms, inadequate pain control
Medical conditions associated with anxiety (4)
Pulmonary - Asthma, COPD, PE, pneumonia
Medical conditions associated with anxiety (5)
Others - Anemias, systemic lupus erythematosus, vestibular dysfunction
Drug-induced anxiety (1)
Sympathomimetics** - Pseudoephedrine
Drug-induced anxiety (2)
Stimulants** - Amphetamines, Methylphenidate, Cocaine
Drug-induced anxiety (3)
Methylxanthines - Theophylline, caffeine
Drug-induced anxiety (4)
Thyroid hormone - Levothyroxine**
Drug-induced anxiety (5)
Corticosteriods** - Prednisolone
Drug-induced anxiety (5)
Antidepressants
Drug-induced anxiety (6)
Beta-adrenergic agonists** - Salbutamol (esp. systemic/oral)
Panic attack duration and frequency
A discrete period of intense fear/discomfort, in which ≥ 4 symptoms developed abruptly and reached a peak w/in 10mins (usually lasts no more than 20-30 min)
Panic attack symptoms
– Palpitations, pounding heart, ↑PR
– Sweating
– Trembling/ shaking
– Sensations of shortness of breath
– Feeling of choking
– Chest pain/ discomfort
– Nausea or abdominal distress
– Feeling dizzy, unsteady, lightheaded, faint
– Derealization (feelings of unreal) or depersonalization (being detached from oneself)
– Fear of losing control or going crazy
– Fear of dying
– Paresthesias (numbness or tingling sensations)
– Chills or hot flushes
GAD duration
Excessive anxiety and worry (apprehensive expectation), occurring more days than not for ≥6 months, about a number of events or activities (e.g. work, school performance).
The person finds it difficult to control.